CYP-eicosanoids - A new link between omega-3 fatty acids and cardiac disease?

Prostaglandins and Other Lipid Mediators

Volumn 96, Issue 1-4, 2011, Pages 99-108

  Westphal, Christina ^a   Konkel, Anne ^a   Schunck, Wolf Hagen ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Arrhythmia; Cardioprotection; Cytochrome P450; DHA; Eicosanoids; EPA

Indexed keywords

5,8,11,14,17 ICOSAPENTAENOIC ACID; ARACHIDONIC ACID; CERVONIC ACID; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2C11; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 3A4; CYTOCHROME P450 4A1; CYTOCHROME P450 4A11; ICOSANOID; ION CHANNEL; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN SYNTHASE;

ANTIARRHYTHMIC ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; DIET SUPPLEMENTATION; ENZYME SUBSTRATE; EPOXIDATION; FATTY ACID METABOLISM; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIC HEART DISEASE; LIPID RAFT; NONHUMAN; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SUDDEN DEATH;

ANIMALS; ANIMALS, NEWBORN; ANTI-ARRHYTHMIA AGENTS; ARACHIDONIC ACID; ARRHYTHMIAS, CARDIAC; CARDIOMEGALY; CARDIOTONIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DEATH, SUDDEN, CARDIAC; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FISH OILS; HUMANS; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; REPERFUSION INJURY;

EID: 81155155630     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.09.001     Document Type: Review

References (115)

1. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 21 2002 2747 2757 (Pubitemid 35364932)
2. C.J. Lavie, R.V. Milani, M.R. Mehra, and H.O. Ventura Omega-3 polyunsaturated fatty acids and cardiovascular diseases J Am Coll Cardiol 54 7 2009 585 594
3. R. De Caterina n-3 fatty acids in cardiovascular disease N Engl J Med 364 25 2011 2439 2450
4. W.E. Lands Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease Ann N Y Acad Sci 1055 2005 179 192 (Pubitemid 43211671)
5. A. Leaf, J.X. Kang, Y.F. Xiao, and G.E. Billman Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils Circulation 107 21 2003 2646 2652 (Pubitemid 36667234)
6. D. Mozaffarian Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death Am J Clin Nutr 87 6 2008 1991S 1996S (Pubitemid 351872680)
7. N.R. Matthan, H. Jordan, M. Chung, A.H. Lichtenstein, D.A. Lathrop, and J. Lau A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models Metabolism 54 12 2005 1557 1565 (Pubitemid 41728145)
8. R. Fischer, R. Dechend, and F. Qadri Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension Hypertension 51 2 2008 540 546 (Pubitemid 351156445)
9. J.Y. Gao, S. Yasuda, and R. Tsuburaya Long-term treatment with eicosapentaenoic acid ameliorates myocardial ischemia-reperfusion injury in pigs in vivo Circ J 75 8 2011 1843 1851
10. J.F. Sarrazin, G. Comeau, and P. Daleau Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs J Am Coll Cardiol 50 15 2007 1505 1512 (Pubitemid 47494587)
11. K. Kitamura, R. Shibata, Y. Tsuji, M. Shimano, Y. Inden, and T. Murohara Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model Am J Physiol Heart Circ Physiol 300 5 2011 H1814 H1821
12. R. Marchioli, F. Barzi, and E. Bomba Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 16 2002 1897 1903 (Pubitemid 34437615)
13. L. Calo, L. Bianconi, and F. Colivicchi N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial J Am Coll Cardiol 45 10 2005 1723 1728 (Pubitemid 40704512)
14. J.K. Virtanen, J. Mursu, S. Voutilainen, and T.P. Tuomainen Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men Circulation 120 23 2009 2315 2321
15. U. Benedetto, E. Angeloni, and G. Melina n-3 polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials J Cardiovasc Med (Hagerstown) 2011 Aug 5 [Epub ahead of print]
16. J. Dyerberg, H.O. Bang, E. Stoffersen, S. Moncada, and J.R. Vane Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2 8081 1978 117 119 (Pubitemid 8373454)
17. L.M. Arterburn, E.B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am J Clin Nutr 83 6 Suppl. 2006 1467S 1476S (Pubitemid 44713087)
18. A.P. Simopoulos The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases Exp Biol Med (Maywood) 233 6 2008 674 688
19. D. Mozaffarian, and E.B. Rimm Fish intake, contaminants, and human health: evaluating the risks and the benefits JAMA 296 15 2006 1885 1899 (Pubitemid 44596197)
20. C. von Schacky, and W.S. Harris Cardiovascular benefits of omega-3 fatty acids Cardiovasc Res 73 2 2007 310 315 (Pubitemid 44937689)
21. W.S. Harris The omega-3 index as a risk factor for coronary heart disease Am J Clin Nutr 87 6 2008 1997S 2002S (Pubitemid 351872681)
22. D.Y. Oh, S. Talukdar, and E.J. Bae GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Cell 142 5 2010 687 698
23. M. Wada, C.J. DeLong, and Y.H. Hong Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products J Biol Chem 282 31 2007 22254 22266 (Pubitemid 47267340)
24. M. Shikano, Y. Masuzawa, K. Yazawa, K. Takayama, I. Kudo, and K. Inoue Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine Biochim Biophys Acta 1212 2 1994 211 216 (Pubitemid 24181661)
25. S.I. Rapoport Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease Prostaglandins Leukot Essent Fatty Acids 79 3-5 2008 153 156
26. A.O. Rosa, and S.I. Rapoport Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids Biochim Biophys Acta 1791 8 2009 697 705
27. C.M. Jenkins, A. Cedars, and R.W. Gross Eicosanoid signalling pathways in the heart Cardiovasc Res 82 2 2009 240 249
28. J. Sharma, and J. McHowat PGE2 release from tryptase-stimulated rabbit ventricular myocytes is mediated by calcium-independent phospholipase A2gamma Lipids 46 5 2011 391 397
29. T. Terano, J.A. Salmon, and S. Moncada Biosynthesis and biological activity of leukotriene B5 Prostaglandins 27 2 1984 217 232
30. D.B. Jump The biochemistry of n-3 polyunsaturated fatty acids J Biol Chem 277 11 2002 8755 8758 (Pubitemid 34952937)
31. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 5 2008 349 361 (Pubitemid 351595216)
32. C.N. Serhan, R. Yang, and K. Martinod Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions J Exp Med 206 1 2009 15 23
33. K.T. Keyes, Y. Ye, and Y. Lin Resolvin E1 protects the rat heart against reperfusion injury Am J Physiol Heart Circ Physiol 299 1 2010 H153 H164
34. J.H. Capdevila, J.R. Falck, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase J Lipid Res 41 2 2000 163 181 (Pubitemid 30117856)
35. J.C. McGiff, and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol 277 3 Pt 2 1999 R607 R623
36. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 1 2002 131 185 (Pubitemid 34654217)
37. D.C. Zeldin Epoxygenase pathways of arachidonic acid metabolism J Biol Chem 276 39 2001 36059 36062
38. A. Konkel, and W.H. Schunck Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids Biochim Biophys Acta 1814 1 2011 210 222
39. E. Barbosa-Sicard, M. Markovic, H. Honeck, B. Christ, D.N. Muller, and W.H. Schunck Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily Biochem Biophys Res Commun 329 4 2005 1275 1281 (Pubitemid 40568707)
40. M. Fer, Y. Dreano, and D. Lucas Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450 Arch Biochem Biophys 471 2 2008 116 125
41. C. Arnold, M. Markovic, and K. Blossey Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids J Biol Chem 285 43 2010 32720 41733
42. D. Lucas, S. Goulitquer, and J. Marienhagen Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450 J Lipid Res 51 5 2010 1125 1133
43. H.R. Knapp, A.J. Miller, and J.A. Lawson Urinary excretion of diols derived from eicosapentaenoic acid during n-3 fatty acid ingestion by man Prostaglandins 42 1 1991 47 54
44. G.C. Shearer, W.S. Harris, T.L. Pedersen, and J.W. Newman Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters J Lipid Res 51 8 2010 2074 2081
45. J.H. Capdevila, and J.R. Falck Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases Prostaglandins Other Lipid Mediat 68-69 2002 325 344 (Pubitemid 35247405)
46. D.C. Zeldin, J. Kobayashi, and J.R. Falck Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase J Biol Chem 268 9 1993 6402 6407 (Pubitemid 23099336)
47. D.C. Zeldin, S. Wei, J.R. Falck, B.D. Hammock, J.R. Snapper, and J.H. Capdevila Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis Arch Biochem Biophys 316 1 1995 443 451
48. A. Karara, E. Dishman, J.R. Falck, and J.H. Capdevila Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties J Biol Chem 266 12 1991 7561 7569 (Pubitemid 21906402)
49. J.H. Capdevila, J.R. Falck, and J.D. Imig Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension Kidney Int 72 6 2007 683 689 (Pubitemid 47373784)
50. W.B. Campbell, and J.R. Falck Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors Hypertension 49 3 2007 590 596
51. I. Fleming Vascular cytochrome p450 enzymes: physiology and pathophysiology Trends Cardiovasc Med 18 1 2008 20 25
52. K. Nithipatikom, and G.J. Gross Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection J Cardiovasc Pharmacol Ther 15 2 2010 112 119
53. K. Nithipatikom, E.R. Gross, and M.P. Endsley Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway Circ Res 95 8 2004 e65 e71
54. J.M. Seubert, D.C. Zeldin, K. Nithipatikom, and G.J. Gross Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury Prostaglandins Other Lipid Mediat 82 1-4 2007 50 59 (Pubitemid 44880163)
55. G.J. Gross, J.R. Falck, E.R. Gross, M. Isbell, J. Moore, and K. Nithipatikom Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited Cardiovasc Res 68 1 2005 18 25 (Pubitemid 41253552)
56. S. Wu, W. Chen, and E. Murphy Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes J Biol Chem 272 19 1997 12551 12559 (Pubitemid 27203348)
57. J. Seubert, B. Yang, and J.A. Bradbury Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway Circ Res 95 5 2004 506 514 (Pubitemid 39180931)
58. S.N. Batchu, E. Law, D.R. Brocks, J.R. Falck, and J.M. Seubert Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model J Mol Cell Cardiol 46 1 2009 67 74
59. G.J. Gross, A. Hsu, J.R. Falck, and K. Nithipatikom Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts J Mol Cell Cardiol 42 3 2007 687 691 (Pubitemid 46349123)
60. G.J. Gross, K.M. Gauthier, and J. Moore Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart Am J Physiol Heart Circ Physiol 294 6 2008 H2838 H2844
61. G.J. Gross, K.M. Gauthier, J. Moore, W.B. Campbell, J.R. Falck, and K. Nithipatikom Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog Am J Physiol Heart Circ Physiol 297 1 2009 H47 H52
62. G.G. Yu, X.J. Zeng, and H.X. Wang Cytochrome P450 2J3/epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat Clin Exp Pharmacol Physiol 38 1 2011 63 70
63. G.J. Gross, J.E. Baker, J. Moore, J.R. Falck, and K. Nithipatikom Abdominal surgical incision induces remote preconditioning of trauma (RPCT) via activation of bradykinin receptors (BK2R) and the cytochrome P450 epoxygenase pathway in canine hearts Cardiovasc Drugs Ther 2011 Jul 26 [Epub ahead of print]
64. Y. Zhang, H. El-Sikhry, and K.R. Chaudhary Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol 297 1 2009 H37 H46
65. D. Xu, N. Li, and Y. He Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors Proc Natl Acad Sci USA 103 49 2006 18733 18738 (Pubitemid 44913479)
66. D. Ai, W. Pang, and N. Li Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy Proc Natl Acad Sci USA 106 2 2009 564 569
67. J. Monti, J. Fischer, and S. Paskas Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease Nat Genet 40 5 2008 529 537 (Pubitemid 351601216)
68. K. Nithipatikom, R.F. DiCamelli, and S. Kohler Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs Anal Biochem 292 1 2001 115 124 (Pubitemid 32417729)
69. ATP channel J Mol Cell Cardiol 37 6 2004 1245 1249 (Pubitemid 39575170)
70. K. Nithipatikom, M.P. Endsley, and J.M. Moore Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection Am J Physiol Heart Circ Physiol 290 2 2006 H500 H505
71. M.H. Yousif, I.F. Benter, and R.J. Roman Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic-reperfusion injury Auton Autacoid Pharmacol 29 1-2 2009 33 41
72. K. Node, Y. Huo, and X. Ruan Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 5431 1999 1276 1279 (Pubitemid 29398616)
73. F. Rompe, M. Artuc, and A. Hallberg Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB Hypertension 55 4 2010 924 931
74. ATP channels J Mol Cell Cardiol 46 6 2009 978 988
75. D. Katragadda, S.N. Batchu, W.J. Cho, K.R. Chaudhary, J.R. Falck, and J.M. Seubert Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells J Mol Cell Cardiol 46 6 2009 867 875
76. 2+ channels and contraction in mammalian heart cells J Physiol 508 Pt 3 1998 777 792 (Pubitemid 28220731)
77. 2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids Prostaglandins Other Lipid Mediat 82 1-4 2007 11 18
78. T. Lu, T. Hoshi, N.L. Weintraub, A.A. Spector, and H.C. Lee Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes J Physiol 537 Pt 3 2001 811 827 (Pubitemid 34026610)
79. H.C. Lee, T. Lu, N.L. Weintraub, M. VanRollins, A.A. Spector, and E.F. Shibata Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes J Physiol 519 Pt 1 1999 153 168 (Pubitemid 29417810)
80. D.J. Hausenloy, A. Tsang, and D.M. Yellon The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning Trends Cardiovasc Med 15 2 2005 69 75 (Pubitemid 40693390)
81. E.R. Gross, A.K. Hsu, and G.J. Gross Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts Circ Res 94 7 2004 960 966 (Pubitemid 38490074)
82. N. Li, J.Y. Liu, and V. Timofeyev Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches J Mol Cell Cardiol 47 6 2009 835 845
83. D.A. Brown, and B. O'Rourke Cardiac mitochondria and arrhythmias Cardiovasc Res 88 2 2010 241 249
84. T. Miura, T. Miki, and T. Yano Role of the gap junction in ischemic preconditioning in the heart Am J Physiol Heart Circ Physiol 298 4 2010 H1115 H1125
85. H. Singh, J. Cheng, and H. Deng Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension Hypertension 50 1 2007 123 129 (Pubitemid 46986020)
86. T. Ishizuka, J. Cheng, and H. Singh 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells J Pharmacol Exp Ther 324 1 2008 103 110 (Pubitemid 350294158)
87. J. Cheng, C.C. Wu, and K.H. Gotlinger 20-Hydroxy-5,8,11,14- eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling J Pharmacol Exp Ther 332 1 2010 57 65
88. M.M. Muthalif, I.F. Benter, and N. Karzoun 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells Proc Natl Acad Sci USA 95 21 1998 12701 12706 (Pubitemid 28483828)
89. A. Yaghi, and S.M. Sims Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle Am J Physiol Lung Cell Mol Physiol 289 6 2005 L1061 L1074
90. 2+ channel via a PKC-dependent mechanism in cardiomyocytes Am J Physiol Heart Circ Physiol 299 4 2010 H1109 H1117
91. Y. Bao, X. Wang, and W. Li 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways J Cardiovasc Pharmacol 57 3 2011 294 301
92. T. Lu, M. VanRollins, and H.C. Lee Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study Mol Pharmacol 62 5 2002 1076 1083 (Pubitemid 35222498)
93. H.C. Hercule, B. Salanova, and K. Essin The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents Exp Physiol 92 6 2007 1067 1076 (Pubitemid 47568840)
94. B. Lauterbach, E. Barbosa-Sicard, and M.H. Wang Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators Hypertension 39 2 Pt 2 2002 609 613 (Pubitemid 34165192)
95. D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.C. Lee, and M. VanRollins Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels J Pharmacol Exp Ther 303 2 2002 768 776 (Pubitemid 35231254)
96. Y. Zhang, C.L. Oltman, T. Lu, H.C. Lee, K.C. Dellsperger, and M. VanRollins EET homologs potently dilate coronary microvessels and activate BK(Ca) channels Am J Physiol Heart Circ Physiol 280 6 2001 H2430 H2440
97. C. Morin, M. Sirois, V. Echave, R. Albadine, and E. Rousseau 17,18-Epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase Am J Respir Cell Mol Biol 43 5 2010 564 575
98. C. Morin, M. Sirois, V. Echave, E. Rizcallah, and E. Rousseau Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung Am J Physiol Lung Cell Mol Physiol 296 1 2009 L130 L139
99. J.X. Kang, and A. Leaf Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes Proc Natl Acad Sci USA 91 21 1994 9886 9890 (Pubitemid 24311913)
100. J.X. Kang, and A. Leaf Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes Biochem Biophys Res Commun 208 2 1995 629 636
101. J.X. Kang, Y.F. Xiao, and A. Leaf Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes Proc Natl Acad Sci USA 92 9 1995 3997 4001
102. J.R. Falck, G. Wallukat, and N. Puli 17(R),18(S)-Epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues J Med Chem 54 12 2011 4109 4118
103. A.A. Spector Arachidonic acid cytochrome P450 epoxygenase pathway J Lipid Res 50 Suppl. 2009 S52 S56
104. Y. Chen, J.R. Falck, V.R. Tuniki, and W.B. Campbell 20-125Iodo-14,15- epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site J Pharmacol Exp Ther 331 3 2009 1137 1145
105. Y. Chen, J.R. Falck, V.L. Manthati, J.L. Jat, and W.B. Campbell 20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor Biochemistry 50 18 2011 3840 3848
106. P.L. Li, and W.B. Campbell Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein Circ Res 80 6 1997 877 884 (Pubitemid 27230063)
107. D. Schwarz, P. Kisselev, A. Chernogolov, W.H. Schunck, and I. Roots Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns Biochem Biophys Res Commun 336 3 2005 779 783 (Pubitemid 41338336)
108. M. Fer, L. Corcos, and Y. Dreano Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism J Lipid Res 49 11 2008 2379 2389
109. D.N. Muller, C. Schmidt, and E. Barbosa-Sicard Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation Biochem J 403 1 2007 109 118 (Pubitemid 46569872)
110. S.D. Harmon, X. Fang, and T.L. Kaduce Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production Prostaglandins Leukot Essent Fatty Acids 75 3 2006 169 177 (Pubitemid 44292521)
111. K. Stark, B. Wongsud, R. Burman, and E.H. Oliw Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8 Arch Biochem Biophys 441 2 2005 174 181 (Pubitemid 41557694)
112. D. Schwarz, P. Kisselev, and S.S. Ericksen Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid Biochem Pharmacol 67 8 2004 1445 1457 (Pubitemid 38388207)
113. J.H. Capdevila, S. Wei, and C. Helvig The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3 J Biol Chem 271 37 1996 22663 22671 (Pubitemid 26304709)
114. G.L. Russo Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention Biochem Pharmacol 77 6 2009 937 946
115. S. Wu, C.R. Moomaw, K.B. Tomer, J.R. Falck, and D.C. Zeldin Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart J Biol Chem 271 7 1996 3460 3468 (Pubitemid 26065653)